Lenzest 25 mg Capsule

Lenzest 25 mg Capsule contains lenalidomide 25 mg, an immunomodulatory anticancer medicine. It is used in the treatment of multiple myeloma and certain blood disorders and lymphomas under specific treatment protocols. The capsule is taken orally under the supervision of a qualified healthcare professional.

BUY NOW

Lenalidomide works by modifying immune-system activity and affecting cancer-cell growth and blood-vessel formation within tumors. Lenzest 25 mg is manufactured by Sun Pharmaceutical Industries Ltd and is supplied as a hard capsule. The product is available in a pack of 10 capsules in India, while regulatory records also document a 3 × 7 capsule presentation for this strength. Regular blood-count monitoring may be required during treatment because lenalidomide can affect blood cells.

Technical Specification

Specification Details
Active Ingredient Lenalidomide
Strength 25 mg
Dosage Form Hard Capsule
Route of Administration Oral
Pack Size 10 capsules
Manufacturer Sun Pharmaceutical Industries Ltd

Product Also Known As

Lenzest 25 mg Capsule, Lenzest 25mg Capsule, Lenalidomide 25 mg Capsule, Lenalidomide 25mg Capsule, Lenalidomide Anticancer Capsule, Lenalidomide Multiple Myeloma Capsule, Immunomodulatory Anticancer Capsule